Elevated protein carbonylation in the brain white matter and gray matter of patients with multiple sclerosis

Oscar A Bizzozero1, Gisela DeJesus, Kelly Callahan

  • 1Department of Cell Biology and Physiology, University of New Mexico-Health Sciences Center, Albuquerque, New Mexico 87131-5218, USA. obizzozero@salud.unm.edu

Insights

Oxidative damage, indicated by increased protein carbonyls (PCOs), occurs in normal-appearing white and gray matter of multiple sclerosis (MS) brains, suggesting widespread biochemical alterations beyond visible lesions.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Oxidative stress is a key factor in multiple sclerosis (MS) pathophysiology.
  • Reactive oxygen species (ROS) from immune cells contribute to substrate oxidation within MS plaques.
  • The extent of oxidative damage in normal-appearing brain tissue in MS is not fully understood.

Purpose of the Study:

  • To investigate oxidative damage in normal-appearing white matter (NAWM) and normal-appearing gray matter (NAGM) of MS brains.
  • To quantify total carbonyls (TCOs) and protein carbonyls (PCOs) in MS brain tissue.
  • To assess the relationship between oxidative damage markers and other biochemical alterations in MS.

Main Methods:

  • Analysis of TCOs and PCOs in post-mortem brain tissue from MS patients and controls.
  • Western blot analysis using 2,4-dinitrophenylhydrazine to detect PCOs.
  • Measurement of glial fibrillary acidic protein (GFAP) and nonprotein thiols.

Main Results:

  • Increased PCOs were found in most MS white matter samples (7/8), correlating with higher GFAP levels.
  • MS gray matter also exhibited significantly elevated TCOs and PCOs (threefold increase) compared to controls.
  • A 30% decrease in nonprotein thiols was observed in both MS white and gray matter, indicating reduced antioxidant capacity.

Conclusions:

  • Biochemical alterations, including oxidative damage, are present in both NAWM and NAGM of MS brains.
  • Increased protein carbonylation in seemingly normal brain tissue suggests widespread oxidative stress in MS.
  • Findings support the involvement of gray matter in MS pathology and highlight the need for therapies targeting oxidative stress.